This week, we've heard from researchers trying to untangle the effects of the "trip" that often comes with psychedelics and ketamine from the ways these drugs might change the human brain. For part three of our series on psychedelic drug research, we get a glimpse into why some researchers are taking the "trip" out of these drugs altogether. You don't need to have heard the previous two episodes to understand this episode on what could be next for psychedelic medicine.
Catch the rest of this series on psychedelics and related drugs this week by following us on Spotify and Apple Podcasts. They're the previous two episodes in our podcast feed.
Have other questions about psychedelics and the brain? Let us know by emailing shortwave@npr.org!
To manage podcast ad preferences, review the links below:
See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.
Learn more about sponsor message choices: podcastchoices.com/adchoices
NPR Privacy Policy
